Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Cell Host & Microbe|May 16, 2020
Identification of Human Single-Domain Antibodies against SARS-CoV-2Yanling Wu, Cheng Li, Shuai Xia, et al.
Small Methods|February 17, 2022
Design of a Novel Fab-Like Antibody Fragment with Enhanced Stability and Affinity for Clinical useChunyu Wang, Jiaxu Hong, Zhenlin Yang, et al.
Ebiomedicine|February 16, 2024
Genomic characteristics and immune landscape of super multiple primary lung cancerZhenlin Yang, Bolun Zhou, Wei Guo, et al.
Cell|August 2, 2024
Activation of the helper NRC4 immune receptor forms a hexameric resistosomeFurong Liu, Zhenlin Yang, Chao Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2022
A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumorsYanling Wu, Quanxiao Li, Yu Kong, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 25, 2025
Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma RecurrenceJinna Ren, Tianjiao Chu, Bozhao Li, et al.
Nature Communications|September 28, 2020
Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinomaZhenlin Yang, Jiachen Xu, Lin Li, et al.
Molecular Cancer|July 16, 2026
Plasma proteomic and metabolomic profiling reveals molecular features relevant to neoadjuvant therapy response in locally advanced esophageal squamous cell carcinomaChu Xiao, Ziqin Deng, Guochao Zhang, et al.
Genome Medicine|August 12, 2022
Molecular profiling of human non-small cell lung cancer by single-cell RNA-seqQingqing Li, Rui Wang, Zhenlin Yang, et al.
BMC Medicine|August 27, 2020
A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patientsYanhua Tian, Jiachen Xu, Qian Chu, et al.
Pageof 17